Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome
Chang Hoon Lee, Tuan Minh Nguyen, Yongook Lee, Seoung Gyu Choi, Phuong Ngan Nguyen, Jung Ho Park, Mi Kyung Park · 2025
Read Overcoming Therapeutic Resistance in Triple-Negative Breast Cancer: Targeting the Undrugged Kinome by Chang Hoon Lee, Tuan Minh Nguyen, Yongook Lee, Seoung Gyu Choi, Phuong Ngan Nguyen, Jung Ho Park, Mi Kyung Park (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12786788.txt.
Description
Chang Hoon Lee and co-authors review new ways to beat drug resistance in triple-negative breast cancer, in a 2025 paper. This is the most aggressive form of breast cancer, with wide variation and few targeted drugs. Chemotherapy is the standard care, but resistance comes fast, driven by cancer stem cells, flexible metabolism, and the tumor's surroundings. Long-term survival stays low as a result.
The review tracks a shift from 2021 to 2025, from broad cell killing toward precision medicine. Early targeted drugs often failed, as tumors found work-arounds and side effects mounted. New plans attack weak points in cell division control, and new drug forms, such as degraders and antibody-drug pairs, open fresh routes. The authors focus on kinases not yet drugged.
Catalog record
| CREATOR | Chang Hoon Lee, Tuan Minh Nguyen, Yongook Lee, Seoung Gyu Choi, Phuong Ngan Nguyen, Jung Ho Park, Mi Kyung Park |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |